| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |